Hua Medicine (Shanghai) Ltd.

Hua Medicine (Shanghai) Ltd.verified

HUMDF

Price:

$0.4107

Market Cap:

$2.91B

Hua Medicine (Shanghai) Ltd. operates as a clinical-stage drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin that is in Phase I clinical trial for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease levodopa-induced dyskinesia. The company was incorpora...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-03-15

Stock Exchange

OTC

Ticker

HUMDF

The PE Ratio as of December 2025 (TTM) for Hua Medicine (Shanghai) Ltd. (HUMDF) is 2.74

According to Hua Medicine (Shanghai) Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 2.74. This represents a change of -227.31% compared to the average of -2.15 of the last 4 quarters.

Hua Medicine (Shanghai) Ltd. (HUMDF) Historical PE Ratio (quarterly & annually)

How has HUMDF PE Ratio performed in the past?

The mean historical PE Ratio of Hua Medicine (Shanghai) Ltd. over the last ten years is -12.07. The current 2.74 PE Ratio has changed -2369.76% with respect to the historical average. Over the past ten years (40 quarters), HUMDF's PE Ratio was at its highest in in the June 2025 quarter at 0.54. The PE Ratio was at its lowest in in the December 2017 quarter at -37.81.

Quarterly (TTM)
Annual

Average

-12.07

Median

-9.85

Minimum

-26.58

Maximum

-0.72

Hua Medicine (Shanghai) Ltd. (HUMDF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Hua Medicine (Shanghai) Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.26%

Maximum Annual PE Ratio = -0.72

Minimum Annual Increase = -97.28%

Minimum Annual PE Ratio = -26.58

Quarterly (TTM)
Annual
YearPE RatioChange
2024-5.38-34.84%
2023-8.26-47.30%
2022-15.6775.45%
2021-8.93-23.54%
2020-11.6818.54%
2019-9.851.26%
2018-0.72-97.28%
2017-26.5823.21%

Hua Medicine (Shanghai) Ltd. (HUMDF) Average PE Ratio

How has HUMDF PE Ratio performed in the past?

The current PE Ratio of Hua Medicine (Shanghai) Ltd. (HUMDF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-9.77

5-year avg

-9.98

10-year avg

-12.07

Hua Medicine (Shanghai) Ltd. (HUMDF) PE Ratio vs. Peers

How is HUMDF’s PE Ratio compared to its peers?

Hua Medicine (Shanghai) Ltd.’s PE Ratio is greater than Allergy Therapeutics plc (-14.31), less than Knight Therapeutics Inc. (1.60K), less than Boiron S.A. (27.57), greater than Cresco Labs Inc. (-6.75), less than PureTech Health plc (7.49), less than Clinuvel Pharmaceuticals Limited (17.07), greater than Hansa Biopharma AB (publ) (-4.42), greater than Nika Pharmaceuticals Inc. (-4920.83), greater than Verano Holdings Corp. (-0.93), less than Ion Beam Applications S.A. (19.71),

Build a custom stock screener for Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hua Medicine (Shanghai) Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hua Medicine (Shanghai) Ltd. (HUMDF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hua Medicine (Shanghai) Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Hua Medicine (Shanghai) Ltd.'s PE Ratio?

How is the PE Ratio calculated for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the highest PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the 3-year average PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

What is the 5-year average PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF)?

How does the current PE Ratio for Hua Medicine (Shanghai) Ltd. (HUMDF) compare to its historical average?